Dubuis Eric, Rockliffe Nichola, Hussain Munir, Boyett Mark, Wray Dennis, Gawler Debra
The Physiological Laboratory, University of Liverpool, Crown Street, Liverpool L69 3BX, United Kingdom.
Cardiovasc Res. 2006 Feb 1;69(2):391-401. doi: 10.1016/j.cardiores.2005.11.006. Epub 2005 Dec 13.
Src has been proposed to activate L-type calcium channel activity by binding to the alpha1c subunit. In the II-III linker region of this subunit there is a novel consensus sequence for Src binding. We have examined whether this site is a functional Src interaction site and investigated the effect displacing Src from this region has on calcium channel activity.
In vitro binding assays were performed to map alpha1 subunit interaction sites. Cardiac myocytes were isolated enzymatically from rat ventricles. Whole cell patch-clamp technique was used to record Ca(2+) channel currents in cells that had been loaded with the Src inhibitor PP1 and/or peptides with amino acid sequence corresponding to the hypothesized Src docking site. Co-immunoprecipitation and pull-down studies were undertaken to identify proteins co-complexing with the alpha1 subunit.
Peptides corresponding to the II-III linker region and C-terminal tail of the alpha1c subunit, but not scrambled peptide controls, were found to inhibit Src SH3 domain binding to the channel and significantly reduced the channel current amplitude. The II-III linker region peptide shifted the inactivation curve to the left whereas the C-terminal tail region peptide shifted the activation curve to the right when compared to scramble peptide controls. PP1-pre-treatment of myocytes also reduced the current amplitude, decreased the V(1/2) for channel inactivation and abolished any further effect on currents by Src binding peptides. The tyrosine kinase PYK2 was found to co-associate with Src and the channel, but PP1 pre-treatment reduced this co-association.
Src binds to both the II-III linker and C-terminal tail regions of the alpha1c subunit to differentially modulate channel activity. PYK2 is also able to co-complex with Src when bound to this region of the channel but only when Src is catalytically active. Together the two kinases may synergistically regulate channel activity.
有人提出Src通过与α1c亚基结合来激活L型钙通道活性。在该亚基的II-III连接区存在一个新的Src结合共有序列。我们研究了该位点是否为功能性Src相互作用位点,并探讨了将Src从该区域置换对钙通道活性的影响。
进行体外结合试验以定位α1亚基相互作用位点。采用酶解法从大鼠心室分离心肌细胞。使用全细胞膜片钳技术记录已加载Src抑制剂PP1和/或具有与假定的Src对接位点相应氨基酸序列的肽的细胞中的Ca(2+)通道电流。进行免疫共沉淀和下拉研究以鉴定与α1亚基共复合的蛋白质。
发现与α1c亚基的II-III连接区和C末端尾相对应的肽,但不是乱序肽对照,可抑制Src SH3结构域与通道的结合,并显著降低通道电流幅度。与乱序肽对照相比,II-III连接区肽使失活曲线向左移动,而C末端尾区肽使激活曲线向右移动。用PP1预处理心肌细胞也降低了电流幅度,降低了通道失活的V(1/2),并消除了Src结合肽对电流的任何进一步影响。发现酪氨酸激酶PYK2与Src和通道共缔合,但PP1预处理减少了这种共缔合。
Src与α1c亚基的II-III连接区和C末端尾区均结合,以不同方式调节通道活性。PYK2在与通道的该区域结合时也能够与Src共复合,但仅当Src具有催化活性时才会如此。这两种激酶可能协同调节通道活性。